Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults.

Thomas SJ, Eckels KH, Carletti I, De La Barrera R, Dessy F, Fernandez S, Putnak R, Toussaint JF, Sun W, Bauer K, Gibbons RV, Innis BL.

Am J Trop Med Hyg. 2013 Jan;88(1):73-88. doi: 10.4269/ajtmh.2012.12-0361. Epub 2012 Dec 3.

2.

Dengue vaccine candidates in development.

Durbin AP, Whitehead SS.

Curr Top Microbiol Immunol. 2010;338:129-43. doi: 10.1007/978-3-642-02215-9_10. Review.

PMID:
19802583
3.

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.

Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J.

Vaccine. 2011 Sep 23;29(42):7229-41. doi: 10.1016/j.vaccine.2011.06.094. Epub 2011 Jul 13. Review.

PMID:
21745521
4.

Identifying protective dengue vaccines: guide to mastering an empirical process.

Halstead SB.

Vaccine. 2013 Sep 23;31(41):4501-7. doi: 10.1016/j.vaccine.2013.06.079. Epub 2013 Jul 26. Review.

5.

Immune response to dengue virus and prospects for a vaccine.

Murphy BR, Whitehead SS.

Annu Rev Immunol. 2011;29:587-619. doi: 10.1146/annurev-immunol-031210-101315. Review.

PMID:
21219187
6.

Using recombinant DNA technology for the development of live-attenuated dengue vaccines.

Lee HC, Butler M, Wu SC.

Enzyme Microb Technol. 2012 Jul 15;51(2):67-72. doi: 10.1016/j.enzmictec.2012.05.005. Epub 2012 May 17. Review.

PMID:
22664189
7.

Dengue virus vaccine development.

Yauch LE, Shresta S.

Adv Virus Res. 2014;88:315-72. doi: 10.1016/B978-0-12-800098-4.00007-6. Review.

PMID:
24373316
8.

Dengue vaccines: challenges, development, current status and prospects.

Ghosh A, Dar L.

Indian J Med Microbiol. 2015 Jan-Mar;33(1):3-15. Review.

9.

Dengue vaccines: implications for dengue control.

Robinson ML, Durbin AP.

Curr Opin Infect Dis. 2017 Oct;30(5):449-454. doi: 10.1097/QCO.0000000000000394. Review.

PMID:
28719400
10.

The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review.

Agarwal R, Wahid MH, Yausep OE, Angel SH, Lokeswara AW.

Acta Med Indones. 2017 Jan;49(1):24-33. Review.

Supplemental Content

Support Center